Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
773,40 €
1,54 %
Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "outperform" rating reaffirmed by Sanford C. Bernstein.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) was downgraded by HSBC Holdings plc from "hold" to "reduce". They now have a $850.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target lowered by Guggenheim from $1,168.00 to $1,163.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
Deutsche_Bank_Aktien in PepsiCo Inc. diskutieren